Revision history of "Use of alemtuzumab and rituximab consolidation in CLL: Pros and cons" (Q84122212)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

7 August 2024

6 October 2022

12 April 2022

4 April 2022

22 March 2022

17 March 2022

20 January 2022

12 January 2022

21 April 2021

17 September 2020

16 July 2020

2 June 2020

3 April 2020

1 February 2020